Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... benefit from particular pharmacological treatments. Opioid receptor antagonists, such as naltrexone hydrochloride, blunt the reinforcing effects of drinking alcohol and this effect is more ...
2009 SEP 21 ... The apparent pA(2) value of J-113397 was 8.0. Antagonist studies using J-113397 and naltrexone revealed that Ro 64-6198 produced NOP receptor-mediated antinociception independent of ...
2009 SEP 28 ... will be covered under the program, which contains medical interventions including naltrexone, Suboxone® and the proprietary PROMETA® Treatment Program, and psychosocial ...
2009 OCT 5 ... as it marks the first commercial availability for EMBEDA™ (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for ...
2009 NOV 3 ... oral bioavailability of the opioid receptor antagonist naloxone (NA) when compared with naltrexone (NX) may be related to a greater interaction of naloxone with the efflux drug ...
2009 SEP 22 ... precipitate withdrawal was examined. First, the potency of two opioid inverse agonists (naltrexone and naloxone) and a neutral antagonist (6 beta-naltrexol) to antagonize fentanyl-induced ...
Subject: Pharmacology and Experimental Therapeutics
2009 NOV 16 ... response of heroin. The behavioral responses were abolished by pretreatment with 1 mg/kg naltrexone. Heroin was detected in brain tissue after injection, but the levels were low and its ...
2009 OCT 19 ... not by the TRPV1 receptor antagonist, capsazepine, or the opioid receptor antagonist, naltrexone. The novel MAGL inhibitor, 4-nitrophenyl 4-(dibenzo[d][1,3] dioxol-5yl(hydroxy) ...
2009 SEP 22 ... period, and this effect was blocked by coadministration of the opioid antagonist naltrexone. The kappa agonist spiradoline decreased locomotor activity when administered alone and ...
Subject: Pharmacology and Experimental Therapeutics
2009 NOV 9 ... and (4) MZ-2 (30 mc M) increased BMD in human osteoblast cells (MG-63) comparable to naltrexone, while morphine inhibited mineral nodule formation," wrote E.D. Marczak and colleagues. ...
2009 NOV 2 ... treatment, withdrawal was precipitated in 7-day-old pups with the opiate antagonist naltrexone. Cells positive for Fos-like immunoreactivity were quantified within select brain ...
2009 SEP 28 ... Nalfurafine hydrochloride is a novel derivative of the opioid receptor antagonist naltrexone. Nalfurafine hydrochloride is a selective kappa-opioid receptor agonist and has a potent ...
2009 OCT 13 ... random breath testing and residential treatment for alcohol dependence (with and without naltrexone)." "Cost-effectiveness is modelled over the life-time of the Australian ...
2009 NOV 9 ... 280-407], respectively). The antinociceptive effect of EM1 was prevented by subcutaneous naltrexone pretreatment. The coadministration of EM1 with KYNA caused an enhanced and/or prolonged ...
2009 NOV 16 ... the dopamine and norepinephrine reuptake antagonist bupropion and the opioid antagonist naltrexone. The proposed dual mechanism of action of the compound involves complementary ...
2009 SEP 21 ... locomotor effects when tested later. Coadministration of the opioid antagonist naltrexone prevented morphine and buprenorphine from producing cross-sensitization. ...
2009 OCT 12 ... associated with aversive and dysphoric states in alcoholics. Pharmacogenetic studies of naltrexone efficacy are in the clinical stages, and recent studies confirmed a differential ...
2009 OCT 6 ... limited access sessions. Following 14 ethanol consumption sessions during adulthood, a naltrexone dose-response challenge (0-0.4 mg/kg) was initiated for both groups. The results of the ...
